Keyphrases
Adenocarcinoma
25%
Autoimmune Disease
25%
Best Response
25%
Checkpoint Inhibition
25%
Checkpoint Inhibitors
100%
Clinical Worsening
25%
Common Ancestry
25%
Endometrial Adenocarcinoma
25%
Endometrial Intraepithelial Neoplasia
25%
Genetic Lineages
25%
Gynecological Cancer
25%
High Status
25%
High-grade Neuroendocrine
25%
Histology
50%
Inhibitor Treatment
100%
Medical Oncologist
25%
Metachronous Tumors
25%
Metagenomic Next-generation Sequencing (mNGS)
25%
Microsatellite Instability-high (MSI-H)
100%
Molecular Diagnostics
25%
Neuroendocrine Cancer
100%
Neuroendocrine Differentiation
25%
Neuroendocrine Response
100%
Neuroendocrine Tumor
25%
Optimal Therapy
25%
Ovarian Neoplasms
25%
Recurrent Endometrial Cancer
100%
Sarcoidosis
50%
Somatic Alterations
25%
Surgical Oncologist
25%
Synchronous Tumors
50%
Treatment Outcome
25%
Tumor
50%
Tumor Evolution
100%
Medicine and Dentistry
Adenocarcinoma
16%
Autoimmune Disease
16%
Diagnosis
16%
Endometrial Cancer
100%
Endometrium Carcinoma
16%
Endometrium Tumor
16%
Female Genital Tract Cancer
16%
Immunotherapy
33%
Malignant Neoplasm
100%
Microsatellite Instability
66%
Neoplasm
100%
Neuroendocrine Differentiation
16%
Neuroendocrine Tumor
16%
Next Generation Sequencing
16%
Oncologist
16%
Ovarian Tumor
16%
Sarcoidosis
33%
Somatics
16%